The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The LIMD1-MYBL1 index as a composite marker for subtype classification and survival prediction for diffuse large B-cell lymphoma patients.
Qinghua Xu
Employment or Leadership Position - bioMérieux
Cong Tan
No relevant relationships to disclose
Shujuan Ni
No relevant relationships to disclose
Lin Yuan
No relevant relationships to disclose
Fei Wu
Employment or Leadership Position - bioMérieux
Fang Liu
Employment or Leadership Position - bioMérieux
Xun Ye
Employment or Leadership Position - bioMérieux
Xia Meng
Employment or Leadership Position - bioMérieux
Weiqi Sheng
No relevant relationships to disclose
Xiang Du
No relevant relationships to disclose